About Us Shaping the future of healthcare Who are we? Your trusted partner in laboratory and medical research. As a leading API manufacturing company in India, we are dedicated to delivering the highest quality products and services to our clients. 456% PREMIUM PLAN 456% PREMIUM PLAN Contact Us 01 A.P.I Carbamazepine Click here 01 A.P.I Carbamazepine Click here 01 A.P.I Carbamazepine Click here BETTER FOR YOU High Quality Test Services 01 Diagnostic Testing 02 Diagnostic Testing 03 Diagnostic Testing 04 Diagnostic Testing 05 Diagnostic Testing 06 Diagnostic Testing BETTER FOR YOU Board members MR. GOPAL SINGH PAL (Chairman and Managing Director) Welcome to GN Pal Speciality Molecules LLP! Discover our commitment to quality, innovation, and excellence in pharmaceutical manufacturing. MR. OJASV PAL (Managing Director) Explore our cutting-edge facilities and dedication to producing pharmaceutical products of exceptional quality. Core Team Mr. Mahendra pratap singh Site – Head Dr. Jintendra Kevat Head-R&D Mr. Mohit Gautam DGM-QA/QC Mr. Surender Singh Sr. Manager- Production Mr. Satpal Singh Head-Engineering Trusted by Industry Leaders What our Clients Say Hear from those who trust us with their API needs and see how we make a difference in their success. They consistently deliver high-quality chemicals and exceptional support. Their reliability has been a game-changer for our production processes. Rajesh KumarProduction Manager We rely on them for top-grade chemicals in our textile processes. Their products and customer service are outstanding. Ajay MehtaOperations Head They are our trusted supplier for industrial chemicals. Their quality and dedication to customer satisfaction are unmatched. Vikram SinghCEO The quality and consistency of their chemicals have improved our manufacturing processes significantly. Their team is always helpful. Sneha PatelQuality Control Manager Previous Next OUR BLOG Explore our Latest Post How are the new APIs Discovered? Read More March 4, 2024 What is Active Pharma Ingredients? Read More March 4, 2024 Telmisartan: The Blood Pressure Solution Read More March 4, 2024 Load More